DANA ALEXANDER: Open Payments
NPI 1922061225 · MURRAY, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,085 in 70 payments from 11 companies in 2025. Trend: 2023 $1,185 · 2024 $999 · 2025 $1,085
Food & beverage: $1,040Education: $45
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 18 | $229 |
| Lilly USA, LLC | 12 | $191 |
| ABBVIE INC. | 14 | $177 |
| AstraZeneca Pharmaceuticals LP | 2 | $157 |
| PFIZER INC. | 13 | $156 |
| Novartis Pharmaceuticals Corporation | 4 | $64 |
| Axsome Therapeutics, Inc. | 2 | $30 |
| Phathom Pharmaceuticals, Inc. | 2 | $28 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
Products named: FARXIGA, Wegovy, MOUNJARO, UBRELVY, NURTEC ODT, LEQVIO, ELIQUIS, Ozempic.
Industry payments across KY — which companies pay providers there.
